Stemcell United Ltd. ( (AU:BP8) ) just unveiled an update.
Stemcell United Ltd. has entered into a research and development agreement with Singapore Polytechnic to develop a probiotic beverage using green seaweed. This collaboration aims to create a health-promoting drink that supports blood sugar management and aligns with Traditional Chinese Medicine principles. The project, led by Singapore Polytechnic’s Future Food Lab, will focus on creating a product with strong consumer appeal and pleasant taste. This initiative marks a significant step in Stemcell United’s commitment to innovative, health-focused products, potentially enhancing consumer wellness and strengthening the company’s market position.
More about Stemcell United Ltd.
Stemcell United Ltd., a subsidiary of BPH Global Ltd., operates in the health and wellness industry with a focus on developing consumable products infused with seaweed-derived nutraceuticals. The company aims to align its products with Traditional Chinese Medicine principles, emphasizing natural and sustainable ingredients.
Current Market Cap: €1.26M
See more data about BP8 stock on TipRanks’ Stock Analysis page.